Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML

Author: Litzow Mr   Dietz Ab   Bulur Pa   Butler Gw   Gastineau Da   Hoering A   Fink Sr   Letendre L   Padley Dj   Paternoster Sf   Tefferi A   Vuk-Pavlović S  

Publisher: Ashgate Publishing Ltd

ISSN: 1465-3249

Source: Cytotherapy, Vol.8, Iss.3, 2006-05, pp. : 290-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content